FDA approves ranibizumab-hkdz as first interchangeable biosimilar ranibizumab available in both vials and prefilled syringesByModern Retina StaffJune 5th 2026
Q&A: Peripheral vision IOL's influence on driving performanceBySara El Aissati, PhD,Roy Reints, PhD,Antonio J. Del Águila-Carrasco, PhD,Christopher Reeves,Johan Le Brun,Julien Adrian, PhD,Carmen Conovas Vidal, PhDJune 3rd 2026
Q&A: Evaluating 24-month outcomes with Abiliti 1-Day in pediatric myopia controlByAlex Nixon, ODJune 1st 2026